Global Single-photon Emission Computed Tomography Market Size study, by Product (Stand-alone SPECT Systems, Hybrid SPECT Systems), by Application (Cardiology, Oncology), by End Use, and Regional Forecasts 2022-2032
Global Single-photon Emission Computed Tomography (SPECT) Market is valued approximately at USD 3.7 billion in 2023 and is anticipated to grow with a moderate CAGR of 2.78% over the forecast period 2024 to 2032. SPECT, a pivotal component of nuclear imaging, delivers functional insights by capturing gamma rays emitted from radiotracers within the body. This non-invasive modality empowers clinicians to assess perfusion, metabolic activity, and organ function—critical in identifying cardiovascular disease, monitoring tumor progression, and evaluating neurological disorders. With continuous hardware evolution and hybrid integration with CT, the technology is redefining diagnostic clarity and enabling more personalized therapeutic approaches.
Several factors are orchestrating the steady growth of the global SPECT market. As the global burden of cardiovascular and oncological diseases escalates, demand for accurate and early-stage diagnostics is intensifying. Hybrid SPECT/CT systems, combining molecular imaging with anatomical precision, are gaining traction due to their enhanced resolution and functional versatility. Additionally, SPECT is increasingly being utilized for theranostic applications, allowing simultaneous diagnosis and treatment planning in oncology. The integration of artificial intelligence is streamlining image acquisition, noise reduction, and reconstruction workflows—paving the way for faster turnaround and heightened diagnostic accuracy.
Despite its clinical advantages, the SPECT market grapples with several constraints. These include the high cost of imaging equipment and radiopharmaceuticals, limited availability of specialized radiologists, and radiation exposure concerns. Additionally, reimbursement disparities and logistical issues in radiotracer supply chains—especially in developing countries—pose adoption hurdles. However, increasing healthcare investments, favorable regulatory support for radiopharmaceutical innovation, and the emergence of compact SPECT systems are mitigating these barriers and broadening the accessibility spectrum.
As regional landscapes evolve, North America remains the epicenter of the SPECT market owing to robust infrastructure, early adoption of hybrid systems, and substantial investments in nuclear cardiology and oncology diagnostics. The U.S. leads the regional front due to comprehensive insurance models and a mature network of nuclear medicine facilities. Europe follows closely, with Germany and the UK investing in public imaging programs and research trials. Meanwhile, Asia Pacific is projected to be the fastest-growing region, driven by increasing cancer prevalence, growing geriatric populations, and rapid modernization of diagnostic services across China, India, and Southeast Asia.
Major market player included in this report are:
By Product
North America
Several factors are orchestrating the steady growth of the global SPECT market. As the global burden of cardiovascular and oncological diseases escalates, demand for accurate and early-stage diagnostics is intensifying. Hybrid SPECT/CT systems, combining molecular imaging with anatomical precision, are gaining traction due to their enhanced resolution and functional versatility. Additionally, SPECT is increasingly being utilized for theranostic applications, allowing simultaneous diagnosis and treatment planning in oncology. The integration of artificial intelligence is streamlining image acquisition, noise reduction, and reconstruction workflows—paving the way for faster turnaround and heightened diagnostic accuracy.
Despite its clinical advantages, the SPECT market grapples with several constraints. These include the high cost of imaging equipment and radiopharmaceuticals, limited availability of specialized radiologists, and radiation exposure concerns. Additionally, reimbursement disparities and logistical issues in radiotracer supply chains—especially in developing countries—pose adoption hurdles. However, increasing healthcare investments, favorable regulatory support for radiopharmaceutical innovation, and the emergence of compact SPECT systems are mitigating these barriers and broadening the accessibility spectrum.
As regional landscapes evolve, North America remains the epicenter of the SPECT market owing to robust infrastructure, early adoption of hybrid systems, and substantial investments in nuclear cardiology and oncology diagnostics. The U.S. leads the regional front due to comprehensive insurance models and a mature network of nuclear medicine facilities. Europe follows closely, with Germany and the UK investing in public imaging programs and research trials. Meanwhile, Asia Pacific is projected to be the fastest-growing region, driven by increasing cancer prevalence, growing geriatric populations, and rapid modernization of diagnostic services across China, India, and Southeast Asia.
Major market player included in this report are:
- Siemens Healthineers AG
- GE Healthcare
- Canon Medical Systems Corporation
- Koninklijke Philips N.V.
- Digirad Corporation
- Bracco Imaging S.p.A.
- Curium Pharma
- Mediso Medical Imaging Systems Ltd.
- Spectrum Dynamics Medical
- MILabs B.V.
- Jubilant Radiopharma
- Hologic, Inc.
- United Imaging Healthcare Co., Ltd.
- Positron Corporation
- Segami Corporation
By Product
- Stand-alone SPECT Systems
- Hybrid SPECT Systems
- Cardiology
- Oncology
- Hospitals
- Diagnostic Imaging Centers
- Research & Academic Institutes
- Ambulatory Surgical Centers
North America
- U.S.
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Historical year – 2022
- Base year – 2023
- Forecast period – 2024 to 2032
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
- Siemens Healthineers AG
- GE Healthcare
- Canon Medical Systems Corporation
- Koninklijke Philips N.V.
- Digirad Corporation
- Bracco Imaging S.p.A.
- Curium Pharma
- Mediso Medical Imaging Systems Ltd.
- Spectrum Dynamics Medical
- MILabs B.V.
- Jubilant Radiopharma
- Hologic, Inc.
- United Imaging Healthcare Co., Ltd.
- Positron Corporation
- Segami Corporation
CHAPTER 1. GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET EXECUTIVE SUMMARY
1.1. Global SPECT Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Application
1.4. Key Trends
1.5. Reimbursement Landscape
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL SPECT MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Equipment Availability
2.3.3.2. Infrastructure Penetration
2.3.3.3. Regulatory Environment
2.3.3.4. Competitive Landscape
2.3.3.5. Cost-Benefit Viability
2.3.4. Demand Side Analysis
2.3.4.1. Reimbursement Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Radiation Safety Considerations
2.3.4.4. Clinical Adoption & Awareness
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL SPECT MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Escalating Cardiovascular & Oncology Burden
3.1.2. Adoption of Hybrid SPECT/CT Systems
3.1.3. Integration of AI in Image Processing
3.2. Market Challenges
3.2.1. High Equipment & Radiopharmaceutical Costs
3.2.2. Radiotracer Supply Chain Constraints
3.3. Market Opportunities
3.3.1. Compact & Portable SPECT Systems
3.3.2. Theranostic & Personalized Medicine Applications
3.3.3. Emerging Market Expansion
CHAPTER 4. GLOBAL SPECT MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Model
4.1.7. Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL SPECT MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)
5.1. Segment Dashboard
5.2. SPECT Market: Stand-alone vs. Hybrid Revenue Trend Analysis, 2022 & 2032
CHAPTER 6. GLOBAL SPECT MARKET SIZE & FORECASTS BY APPLICATION (2022-2032)
6.1. Segment Dashboard
6.2. SPECT Market: Cardiology vs. Oncology Revenue Trend Analysis, 2022 & 2032
CHAPTER 7. GLOBAL SPECT MARKET SIZE & FORECASTS BY END USE (2022-2032)
7.1. Hospitals
7.2. Diagnostic Imaging Centers
7.3. Research & Academic Institutes
7.4. Ambulatory Surgical Centers
CHAPTER 8. GLOBAL SPECT MARKET SIZE & FORECASTS BY REGION (2022-2032)
8.1. North America SPECT Market
8.1.1. U.S. SPECT Market
8.1.1.1. Product Type Breakdown & Forecasts
8.1.1.2. Application Breakdown & Forecasts
8.1.2. Canada SPECT Market
8.2. Europe SPECT Market
8.2.1. UK
8.2.2. Germany
8.2.3. France
8.2.4. Spain
8.2.5. Italy
8.2.6. Rest of Europe
8.3. Asia Pacific SPECT Market
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Australia
8.3.5. South Korea
8.3.6. Rest of Asia Pacific
8.4. Latin America SPECT Market
8.4.1. Brazil
8.4.2. Mexico
8.5. Middle East & Africa SPECT Market
8.5.1. Saudi Arabia
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Siemens Healthineers AG
9.1.2. GE Healthcare
9.1.3. Canon Medical Systems Corporation
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Siemens Healthineers AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. GE Healthcare
9.3.3. Canon Medical Systems Corporation
9.3.4. Koninklijke Philips N.V.
9.3.5. Digirad Corporation
9.3.6. Bracco Imaging S.p.A.
9.3.7. Curium Pharma
9.3.8. Mediso Medical Imaging Systems Ltd.
9.3.9. Spectrum Dynamics Medical
9.3.10. MILabs B.V.
9.3.11. Jubilant Radiopharma
9.3.12. Hologic, Inc.
9.3.13. United Imaging Healthcare Co., Ltd.
9.3.14. Positron Corporation
9.3.15. Segami Corporation
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
1.1. Global SPECT Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Application
1.4. Key Trends
1.5. Reimbursement Landscape
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL SPECT MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Equipment Availability
2.3.3.2. Infrastructure Penetration
2.3.3.3. Regulatory Environment
2.3.3.4. Competitive Landscape
2.3.3.5. Cost-Benefit Viability
2.3.4. Demand Side Analysis
2.3.4.1. Reimbursement Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Radiation Safety Considerations
2.3.4.4. Clinical Adoption & Awareness
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL SPECT MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Escalating Cardiovascular & Oncology Burden
3.1.2. Adoption of Hybrid SPECT/CT Systems
3.1.3. Integration of AI in Image Processing
3.2. Market Challenges
3.2.1. High Equipment & Radiopharmaceutical Costs
3.2.2. Radiotracer Supply Chain Constraints
3.3. Market Opportunities
3.3.1. Compact & Portable SPECT Systems
3.3.2. Theranostic & Personalized Medicine Applications
3.3.3. Emerging Market Expansion
CHAPTER 4. GLOBAL SPECT MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Model
4.1.7. Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL SPECT MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)
5.1. Segment Dashboard
5.2. SPECT Market: Stand-alone vs. Hybrid Revenue Trend Analysis, 2022 & 2032
CHAPTER 6. GLOBAL SPECT MARKET SIZE & FORECASTS BY APPLICATION (2022-2032)
6.1. Segment Dashboard
6.2. SPECT Market: Cardiology vs. Oncology Revenue Trend Analysis, 2022 & 2032
CHAPTER 7. GLOBAL SPECT MARKET SIZE & FORECASTS BY END USE (2022-2032)
7.1. Hospitals
7.2. Diagnostic Imaging Centers
7.3. Research & Academic Institutes
7.4. Ambulatory Surgical Centers
CHAPTER 8. GLOBAL SPECT MARKET SIZE & FORECASTS BY REGION (2022-2032)
8.1. North America SPECT Market
8.1.1. U.S. SPECT Market
8.1.1.1. Product Type Breakdown & Forecasts
8.1.1.2. Application Breakdown & Forecasts
8.1.2. Canada SPECT Market
8.2. Europe SPECT Market
8.2.1. UK
8.2.2. Germany
8.2.3. France
8.2.4. Spain
8.2.5. Italy
8.2.6. Rest of Europe
8.3. Asia Pacific SPECT Market
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Australia
8.3.5. South Korea
8.3.6. Rest of Asia Pacific
8.4. Latin America SPECT Market
8.4.1. Brazil
8.4.2. Mexico
8.5. Middle East & Africa SPECT Market
8.5.1. Saudi Arabia
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Siemens Healthineers AG
9.1.2. GE Healthcare
9.1.3. Canon Medical Systems Corporation
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Siemens Healthineers AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. GE Healthcare
9.3.3. Canon Medical Systems Corporation
9.3.4. Koninklijke Philips N.V.
9.3.5. Digirad Corporation
9.3.6. Bracco Imaging S.p.A.
9.3.7. Curium Pharma
9.3.8. Mediso Medical Imaging Systems Ltd.
9.3.9. Spectrum Dynamics Medical
9.3.10. MILabs B.V.
9.3.11. Jubilant Radiopharma
9.3.12. Hologic, Inc.
9.3.13. United Imaging Healthcare Co., Ltd.
9.3.14. Positron Corporation
9.3.15. Segami Corporation
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
LIST OF TABLES
TABLE 1. Global SPECT market, report scope
TABLE 2. Global SPECT market estimates & forecasts by Region 2022-2032 (USD Million)
TABLE 3. Global SPECT market estimates & forecasts by Product 2022-2032 (USD Million)
TABLE 4. Global SPECT market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 5. Global SPECT market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 6. North America SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 7. Europe SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 8. Asia Pacific SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 9. Latin America SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 10. Middle East & Africa SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 11. U.S. SPECT market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. Canada SPECT market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. UK SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 14. Germany SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 15. France SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 16. Spain SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 17. Italy SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 18. China SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 19. India SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 20. Japan SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 1. Global SPECT market, report scope
TABLE 2. Global SPECT market estimates & forecasts by Region 2022-2032 (USD Million)
TABLE 3. Global SPECT market estimates & forecasts by Product 2022-2032 (USD Million)
TABLE 4. Global SPECT market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 5. Global SPECT market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 6. North America SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 7. Europe SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 8. Asia Pacific SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 9. Latin America SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 10. Middle East & Africa SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 11. U.S. SPECT market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. Canada SPECT market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. UK SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 14. Germany SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 15. France SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 16. Spain SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 17. Italy SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 18. China SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 19. India SPECT market estimates & forecasts 2022-2032 (USD Million)
TABLE 20. Japan SPECT market estimates & forecasts 2022-2032 (USD Million)
LIST OF FIGURES
FIG 1. Global SPECT market, research methodology
FIG 2. Global SPECT market, market estimation techniques
FIG 3. Global SPECT market size estimation & forecast methods
FIG 4. Global SPECT market, key trends 2023
FIG 5. Global SPECT market, growth prospects 2022-2032
FIG 6. Global SPECT market, Porter’s Five Forces model
FIG 7. Global SPECT market, PESTEL analysis
FIG 8. Global SPECT market, value chain analysis
FIG 9. SPECT market by segment 2022 & 2032 (USD Million)
FIG 10. SPECT market by application 2022 & 2032 (USD Million)
FIG 11. SPECT market by end use 2022 & 2032 (USD Million)
FIG 12. North America SPECT market regional snapshot 2022 & 2032
FIG 13. Europe SPECT market regional snapshot 2022 & 2032
FIG 14. Asia Pacific SPECT market regional snapshot 2022 & 2032
FIG 15. Latin America SPECT market regional snapshot 2022 & 2032
FIG 16. Middle East & Africa SPECT market regional snapshot 2022 & 2032
FIG 17. Global SPECT market, company market share analysis 2023
FIG 18. SPECT market, AI integration impact
FIG 19. SPECT/CT hybrid adoption trend
FIG 20. SPECT radiotracer pipeline overview
FIG 1. Global SPECT market, research methodology
FIG 2. Global SPECT market, market estimation techniques
FIG 3. Global SPECT market size estimation & forecast methods
FIG 4. Global SPECT market, key trends 2023
FIG 5. Global SPECT market, growth prospects 2022-2032
FIG 6. Global SPECT market, Porter’s Five Forces model
FIG 7. Global SPECT market, PESTEL analysis
FIG 8. Global SPECT market, value chain analysis
FIG 9. SPECT market by segment 2022 & 2032 (USD Million)
FIG 10. SPECT market by application 2022 & 2032 (USD Million)
FIG 11. SPECT market by end use 2022 & 2032 (USD Million)
FIG 12. North America SPECT market regional snapshot 2022 & 2032
FIG 13. Europe SPECT market regional snapshot 2022 & 2032
FIG 14. Asia Pacific SPECT market regional snapshot 2022 & 2032
FIG 15. Latin America SPECT market regional snapshot 2022 & 2032
FIG 16. Middle East & Africa SPECT market regional snapshot 2022 & 2032
FIG 17. Global SPECT market, company market share analysis 2023
FIG 18. SPECT market, AI integration impact
FIG 19. SPECT/CT hybrid adoption trend
FIG 20. SPECT radiotracer pipeline overview
